Updated:
New Orleans BioFund
New Orleans BioFund is a life-sciences investment entity based in New Orleans, with additional offices in Princeton and San Francisco.
New Orleans BioFund
New Orleans BioFund is a life-sciences investment entity based in New Orleans, with additional offices in Princeton and San Francisco. The firm's founding year and primary wealth source are not publicly disclosed. Its structure likely aligns with a family office or closely held investment firm focused on biotechnology. The firm targets early- to mid-stage biotech and pharmaceutical companies. It may invest across drug development, medical devices, and diagnostic platforms, though specific portfolio companies or co-investment partners are not publicly recorded. The geographic spread from the Gulf Coast to the East and West Coasts suggests a national deal-sourcing strategy. New Orleans BioFund is part of a broader trend of specialized investment vehicles emerging from regional biotech hubs. No recent operational events or team-size data are available in public records. The firm maintains a low public profile with no disclosed AUM or named principals. Structurally, the firm stands out for its multi-city model linking a Southern biotech hub with established life-sciences centers in New Jersey and California. This architecture may enable it to source deals from both academic spinouts and commercial-stage companies across regions.
General information
Firm type
Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New Orleans
Corporate office
New Orleans, LA, United States
Additional offices
Princeton, NJ · San Francisco, CA
Sector focus
Frequently asked questions
What investment stages does New Orleans BioFund target?
The firm appears to focus on early- to mid-stage biotech and pharmaceutical companies. Its office locations in New Orleans, Princeton, and San Francisco suggest a network that spans academic research centers and commercial biotech clusters. Exact stage preferences are not publicly specified.
Which sectors does New Orleans BioFund invest in?
The firm's name and geographic footprint indicate a focus on life sciences, including biotechnology, pharmaceuticals, and healthcare services. Specific sector exclusions or preferences are not disclosed in public sources.
Does New Orleans BioFund participate in fund commitments or only direct deals?
The firm's investment structure is not publicly documented. Based on its name and limited public profile, it may engage in direct investments in private biotech companies. No evidence of fund-of-funds or third-party fund commitments is available.
Is New Orleans BioFund structured as a single family office or a venture firm?
Public records do not specify the firm's legal structure. Its multi-city footprint and private-investment focus suggest it could operate as a family office or a closely held investment firm rather than a traditional venture capital fund. No regulatory filings or registration details are publicly available.
Where does the underlying wealth for New Orleans BioFund come from?
The origin of capital for New Orleans BioFund is not disclosed. The firm does not publicly name its benefactors or principals, and no wealth-origin details appear in public records or press.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: